Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 16, 2024
Self-heating mitochondrion-induced free radical blast for immunogenic cell death stimulation and HCC immunotherapyMengyun Peng, Hongyan Dong, Meiyu Shao, et al.
Heliyon|February 7, 2024
Evaluate the clinical efficacy of traditional Chinese Medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis: A systematic review and meta-analysisAn Tu, Xiaoning Zhu, Paniz Zarghami Dastjerdi, et al.
ACS Nano|March 1, 2022
Physiologically Inspired Mucin Coated Escherichia coli Nissle 1917 Enhances Biotherapy by Regulating the Pathological Microenvironment to Improve Intestinal ColonizationXinyuan Yang, Jiali Yang, Zihan Ye, et al.
ACS Central Science|July 31, 2023
Calcium Tungstate Microgel Enhances the Delivery and Colonization of Probiotics during Colitis via Intestinal Ecological Niche OccupancyJiali Yang, Mengyun Peng, Shaochong Tan, et al.
Journal of Pharmaceutical Analysis|September 9, 2024
Renal tubular epithelial cell quality control mechanisms as therapeutic targets in renal fibrosisYini Bao, Qiyuan Shan, Keda Lu, et al.
Canadian Journal of Gastroenterology & Hepatology|July 7, 2018
Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-AnalysisXiaolong Qi, Min An, Tongwei Wu, et al.
Nano Letters|October 24, 2018
Real-Time Imaging of Free Radicals for Mitochondria-Targeting Hypoxic Tumor TherapyXiao-Qiang Wang, Mengyun Peng, Chu-Xin Li, et al.
Communications Biology|February 16, 2023
Nanodrug rescues liver fibrosis via synergistic therapy with H2O2 depletion and Saikosaponin b1 sustained releaseHongyan Dong, Xin Han, Min Hao, et al.
Biomarkers in Medicine|August 8, 2025
Systemic immune-inflammation index as a biomarker for stroke prognosis: insights from a multi-time point analysisYanan Wang, Jiaojiao Wang, Fengmei Tian, et al.
Frontiers in Pharmacology|October 7, 2024
Protective effect of MP-40 mitigates BDL-induced hepatic fibrosis by inhibiting the NLRP3-mediated pyroptosisXuedong Wan, Yuanyuan Fang, Minjing Qin, et al.
Pageof 5